Aseptic meningoencephalitis during nusinersen therapy in a patient with type III spinal muscular atrophy: a case report

Key Points

• Aseptic meningoencephalitis was observed in a patient receiving nusinersen therapy.
• The report identifies key symptoms associated with the condition, impacting treatment decisions.
• Detailed evaluations included clinical assessments and imaging studies to confirm diagnosis.
• The case suggests potential risks linked to nusinersen therapy; further investigation is essential.